Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
PHACE syndrome in Adult
Other Resources UpToDate PubMed

PHACE syndrome in Adult

Contributors: Nnenna Agim MD, FAAD, Tracy Fuhrmann MD, Brian Poligone MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

PHACE(S) syndrome (posterior fossa malformations, hemangioma, arterial anomalies, coarctation of the aorta and cardiac defects, eye / endocrine abnormalities, sternal defects) represents a neurocutaneous entity most often recognized by the presence of a large (> 5 cm) hemangioma occupying a facial segment. The hemangioma may occur on the face, scalp, or cervical region and adjacent upper extremity. About 90% of patients have infantile hemangiomas located on the head; 70% of those affected will have only one other extracutaneous manifestation of the syndrome. The most common extracutaneous finding is an arterial anomaly. Dysgenesis, anomalous origin, and narrowing, respectively, are the most frequent arterial anomalies, the presence of which confers risk for hypoperfusion, thrombosis, and cerebral infarction, eventuating in seizures and developmental delay. Examples include arterial aneurysms, anomalous branching of the carotid artery, or coarctation of the aorta. Other potentially associated features include Dandy-Walker malformation (ie, cerebellar vermis agenesis or hypoplasia, cystic dilatation of the fourth ventricle, and enlarged posterior fossa) and cardiac septal defects. Eye abnormalities include congenital cataracts, increased vascularity, microphthalmia, and hypoplasia of the optic nerve. When sternal defects such as clefting and supraumbilical abdominal raphe are present, the constellation of findings is termed PHACES syndrome instead of PHACE syndrome.

PHACE syndrome is thought to arise from a developmental error occurring during the early vasculogenesis of the first trimester. Ninety percent of those affected are female, and no familial tendency is known. PHACE syndrome can be diagnosed by the presence of the large segmental hemangioma and 1 major or 2 minor criteria; possible PHACE syndrome is ascertained when the hemangioma is only accompanied by 1 minor criterion (see References).

There appears to be some correlation between the facial segment occupied by the hemangioma and the underlying vascular / structural malformations. For instance, hemangiomas involving segments 1 and 4, the frontotemporal and frontonasal areas, have a higher risk for cerebrovascular and ophthalmologic defects. Hemangiomas involving mandibular segment 3 have an increased incidence of midline and cardiovascular defects, in addition to the laryngeal involvement associated with this area. Interestingly, if the hemangioma is unilateral, underlying structural anomalies of the brain tend to occur on the same side, presumably from a contiguous defect.

Other emerging associations that may present beyond infancy include headaches, speech delay, auditory anomalies, dysphagia, delayed puberty, and dental anomalies.

Codes

ICD10CM:
Q87.89 – Other specified congenital malformation syndromes, not elsewhere classified

SNOMEDCT:
78572006 – Neurocutaneous syndrome

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:05/10/2020
Last Updated:01/20/2022
Copyright © 2024 VisualDx®. All rights reserved.
PHACE syndrome in Adult
A medical illustration showing key findings of PHACE syndrome : Seizures, Face, Hearing loss, Red color, Scalp, Strabismus, Vascular plaque, Dysphagia, Proptosis, Developmental delay
Clinical image of PHACE syndrome - imageId=1708188. Click to open in gallery.  caption: 'A sizeable deep red plaque (hemangioma) on the scalp.'
A sizeable deep red plaque (hemangioma) on the scalp.
Copyright © 2024 VisualDx®. All rights reserved.